These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11175425)

  • 21. Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.
    Mathiasen LS; Mirza NR; Rodgers RJ
    Pharmacol Biochem Behav; 2008 Jul; 90(1):19-36. PubMed ID: 18321566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct effects of diazepam and NK1 receptor antagonists in two conflict procedures in rats.
    Loiseau F; Le Bihan C; Hamon M; Thiébot MH
    Behav Pharmacol; 2003 Sep; 14(5-6):447-55. PubMed ID: 14501257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological analysis of the effects of benzodiazepines on punished schedule-induced polydipsia in rats.
    Pellón R; Ruíz A; Lamas E; Rodríguez C
    Behav Pharmacol; 2007 Feb; 18(1):81-7. PubMed ID: 17218801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of some benzodiazepines on punished and unpunished behavior in the pigeon.
    Wuttke W; Kelleher RT
    J Pharmacol Exp Ther; 1970 Apr; 172(2):397-405. PubMed ID: 5441161
    [No Abstract]   [Full Text] [Related]  

  • 25. [Behavioral models of anxiety in animals].
    Thiebot MH
    Encephale; 1983; 9(4 Suppl 2):167B-176B. PubMed ID: 6144511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test.
    Britton KT; Morgan J; Rivier J; Vale W; Koob GF
    Psychopharmacology (Berl); 1985; 86(1-2):170-4. PubMed ID: 3927353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buspirone effects in an animal conflict procedure: comparison with diazepam and phenobarbital.
    McCloskey TC; Paul BK; Commissaris RL
    Pharmacol Biochem Behav; 1987 May; 27(1):171-5. PubMed ID: 3615539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Destruction of the locus coeruleus or the dorsal NE bundle does not alter the release of punished responding by ethanol and chlordiazepoxide.
    Koob GF; Thatcher-Britton K; Britton DR; Roberts DC; Bloom FE
    Physiol Behav; 1984 Sep; 33(3):479-85. PubMed ID: 6542682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphetamine potentiation of anti-conflict action of chlordiazepoxide.
    Lerner T; Feldon J; Myslobodsky MS
    Pharmacol Biochem Behav; 1986 Feb; 24(2):241-6. PubMed ID: 3513210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar effects of buspirone and chlordiazepoxide on a fixed interval schedule with long-term, low-dose administration.
    Zhu XO; McNaughton N
    J Psychopharmacol; 1995 Jan; 9(4):326-30. PubMed ID: 22298397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generalization of behavioral history across responses in the reversal of the effects of cocaine and d-amphetamine on the punished behavior of squirrel monkeys.
    Tatham TA; Gyorda AM; Barrett JE
    Behav Pharmacol; 1993 Feb; 4(1):61-68. PubMed ID: 11224172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
    Crespi F
    J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of anxiolytics (1)--Geller-type conflict tests].
    Kuribara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):115-23. PubMed ID: 7796316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
    Rodgers RJ; Gentsch C; Hoyer D; Bryant E; Green AJ; Kolokotroni KZ; Martin JL
    Behav Brain Res; 2004 Sep; 154(1):183-92. PubMed ID: 15302124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Geller-Seifter conflict paradigm with incremental shock.
    Pollard GT; Howard JL
    Psychopharmacology (Berl); 1979 Apr; 62(2):117-21. PubMed ID: 37541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shock avoidance but not DRL history reverses the effects of cocaine on punished behavior of squirrel monkeys.
    Tatham TA; Barrett JE
    Behav Pharmacol; 1993 Apr; 4(2):159-166. PubMed ID: 11224182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis.
    Resstel LB; Alves FH; Reis DG; Crestani CC; Corrêa FM; Guimarães FS
    Neuroscience; 2008 Jun; 154(3):869-76. PubMed ID: 18479825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable-ratio schedules of timeout from avoidance: effects of anxiolytic drugs.
    Galizio M; Hale KL; Liborio MO; Miller M
    Behav Pharmacol; 1993 Oct; 4(5):487-493. PubMed ID: 11224215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.